Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression
Metabolism Aug 12, 2017
Gong Y, et al. – The scientists aimed to explore the impact of thyroid stimulating hormone (TSH) on hepatic proprotein convertase subtilisin/kexin type 9 (PCSK9) expression and low–density lipoprotein cholesterol (LDL–c) metabolism. They discovered a regulating role of TSH on hepatic PCSK9 expression, which further contributes to a higher LDL–c level.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries